Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.

PloS one - 1 Jan 2013

Sorich Michael J, Coory Michael, Pekarsky Brita A K

Abstract excerpt

Evidence of clinical utility is a key issue in translating pharmacogenomics into clinical practice. Appropriately designed randomized controlled trials generally provide the most robust evidence of the clinical utility, but often only data from a pharmacogenomic association study are available. This paper details a method for reframing the results of pharmacogenomic association studies in terms of the comparative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cardiovascular Diseases
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Cytochrome P-450 CYP2C19

Share to Platelet Aggregation Inhibitors

Share to Randomized Controlled Trials as Topic

Share to Ticlopidine

Source

Open in PubMed Open full text

Identifiers

PMID: 24015225
DOI: 10.1371/journal.pone.0072256
PMCID: PMC3754999

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.PMID 24015225Read ↗

The Triangulation WIthin A STudy (TWIST) framework for causal inference within Pharmacogenetic researchSemantic proximity Read ↗

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score.Semantic proximity Read ↗

Multiple comparisons of drug efficacy between subgroups defined by genetic polymorphisms.Semantic proximity Read ↗

Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials.Semantic proximity Read ↗

Graphing and reporting heterogeneous treatment effects through reference classesSemantic proximity Read ↗

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset.Semantic proximity Read ↗

On Bayesian methods of exploring qualitative interactions for targeted treatment.Semantic proximity Read ↗

The R.O.A.D. to clinical trial emulationSemantic proximity Read ↗

Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.Semantic proximity Read ↗

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.Semantic proximity Read ↗

Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker.Semantic proximity Read ↗

Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.